According to Legend Biotech's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 28.8168. At the end of 2023 the company had a P/S ratio of 38.5.
Year | P/S ratio | Change |
---|---|---|
2023 | 38.5 | -46.14% |
2022 | 71.4 | -23.69% |
2021 | 93.6 | 89.11% |
2020 | 49.5 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |